Haplotype analysis of the β2 adrenergic receptor gene and risk of myocardial infarction in humans

Genetics

Volumn 169, Issue 3, 2005, Pages 1583-1587

  Zee, Robert Y L ^a   Cook, Nancy R ^a   Reynolds, Rebecca ^b   Cheng, Suzanne ^c   Ridker, Paul M ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b BAYER CORPORATION   (United States)

^c ROCHE MOLECULAR SYSTEMS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA 2 ADRENERGIC RECEPTOR;

ADULT; ARTICLE; CARDIOVASCULAR RISK; CONTROLLED STUDY; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC EPIDEMIOLOGY; GENETIC POLYMORPHISM; HAPLOTYPE; HEART INFARCTION; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; PHENOTYPIC VARIATION; PRIORITY JOURNAL; RECEPTOR GENE; COHORT ANALYSIS; GENE LINKAGE DISEQUILIBRIUM; GENETIC VARIABILITY; GENETICS; MALE; RISK; RISK FACTOR; SINGLE NUCLEOTIDE POLYMORPHISM; UNITED STATES;

COHORT STUDIES; GENE FREQUENCY; HAPLOTYPES; HUMANS; LINKAGE DISEQUILIBRIUM; MALE; MYOCARDIAL INFARCTION; ODDS RATIO; POLYMORPHISM, SINGLE NUCLEOTIDE; RECEPTORS, ADRENERGIC, BETA-2; RISK FACTORS; UNITED STATES; VARIATION (GENETICS);

EID: 17444375597     PISSN: 00166731     EISSN: None     Source Type: Journal    
DOI: 10.1534/genetics.104.037812     Document Type: Article

References (18)

1. CHENG, S., M. A. GROW, C. PALLAUD, W. KLITZ, H. A. ERLICH et al., 1999 A multilocus genotyping assay for candidate markers of cardiovascular disease risk. Genome Res. 9: 936-949.
2. D'AMATO, M., L. R. VITIANI, G. PETRELLI, L. FERRIGNO, A. DI PIETRO et al., 1998 Association of persistent bronchial hyperresponsiveness with beta2-adrenoceptor (ADRB2) haplotypes. A population study. Am. J. Respir. Crit. Care Med. 158: 1968-1973.
3. DRYSDALE, C. M., D. W. MCGRAW, C. B. STACK, J. C. STEPHENS, R. S. JUDSON et al., 2000 Complex promoter and coding region beta 2-adrenergic receptor haplotypes alter receptor expression and predict in vivo responsiveness. Proc. Natl. Acad. Sci. USA 97: 10483-10488.
4. GREEN, S. A., G. COLE, M. JACINTO, M. INNIS and S. B. LIGGETT, 1993 A polymorphism of the human beta 2-adrenergic receptor within the fourth transmembrane domain alters ligand binding and functional properties of the receptor. J. Biol. Chem. 268: 23116-23121.
5. GREEN, S. A., J. TURKI, M. INNIS, and S. B. LIGGETT, 1994 Amino-terminal polymorphisms of the human beta 2-adrenergic receptor impart distinct agonist-promoted regulatory properties. Biochemistry 33: 9414-9419 (erratum: Biochemistry 33: 14368).
6. GREEN, S. A., J. TURKI, P. BEJARANO, I. P. HALL and S. B. LIGGETT, 1995 Influence of beta 2-adrenergic receptor genotypes on signal transduction in human airway smooth muscle cells. Am. J. Respir. Cell Mol. Biol. 13: 25-33.
7. HERRMANN, S. M., V. NICAUD, L. TIRET, A. EVANS, F. KEE et al., 2002 Polymorphisms of the beta 2-adrenoceptor (ADRB2) gene and essential hypertension: the ECTIM and PEGASE studies. J. Hypertens. 20: 229-235.
8. HOFFSTEDT, J., A. ILIADOU, N. L. PEDERSEN, M. SCHALLING and P. ARNER, 2001 The effect of the beta(2) adrenoceptor gene Thr164Ile polymorphism on human adipose tissue lipolytic function. Br. J. Pharmacol. 133: 708-712.
9. JOHNSON, J. A., and S. G. TERRA, 2002 Beta-adrenergic receptor polymorphisms: cardiovascular disease associations and pharmacogenetics. Pharm. Res. 19: 1779-1787.
10. KAY, L. J., L. K. CHONG, A. ROSTAMI-HODJEGAN and P. T. PEACHELL, 2003 Influence of the thr164ile polymorphism in the beta(2)-adrenoceptor on the effects of beta-adrenoceptor agonists on human lung mast cells. Int. Immunopharmacol. 3: 91-95.
11. LIGGETT, S. B., L. E. WAGONER, L. L. CRAFT, R. W. HORNUNG, B. D. HOIT et al., 1998 The Ile164 beta2-adrenergic receptor polymorphism adversely affects the outcome of congestive heart failure. J. Clin. Invest. 102: 1534-1539.
12. QIN, Z. S., T. NIU and J. S. LIU, 2002 Partition-ligation-expectation- maximization algorithm for haplotype inference with single-nucleotide polymorphisms. Am. J. Hum. Genet. 71: 1242-1247.
13. SCHAID, D. J., 2002 Relative efficiency of ambiguous vs. directly measured haplotype frequencies. Genet. Epidemiol. 23: 426-443.
14. SCHAID, D. J., C. M. ROWLAND, D. E. TINES, R. M. JACOBSON and G. A. POLAND, 2002 Score tests for association between traits and haplotypes when linkage phase is ambiguous. Am. J. Hum. Genet. 70: 425-434.
15. STEERING COMMITTEE OF THE PHYSICIANS' HEALTH STUDY RESEARCH GROUP, 1989 Final report of the aspirin component of the ongoing Physicians' Health Study. N. Engl. J. Med. 321: 129-135.
16. TERWILLIGER, J., and J. OTT, 1994 Handbook of Human Genetic Linkage. Johns Hopkins University Press, Baltimore.
17. WALLENSTEIN, S., S. E. HODGE and A. WESTON, 1998 Logistic regression model for analyzing extended haplotype data. Genet. Epidemiol. 15: 173-181.
18. ZEE, R. Y. L., J. HOH, S. CHENG, R. REYNOLDS, M. A. GROW et al., 2002 Multi-locus interactions predict risk for post-PTCA restenosis: an approach to the genetic analysis of common complex disease. Pharmacogenomics J. 2: 197-201.